Toward transgenic multicellular parasites: CRISPR-Cas12a germline editing of Schistosoma mansoni eggs as key to success
Science Advances · 2026
DOI: 10.1126/sciadv.aeh0455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Max F Moescheid und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Parasitology, Biomedical Research Center Seltersberg (BFS), Justus Liebig University Giessen, Germany. Hauptthemen laut MEDLINE: Schistosoma mansoni, CRISPR-Cas Systems, Gene Editing. Die Arbeit nennt 166 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Lack of transgenesis methods impedes functional studies in platyhelminths. We present a substantially improved ribonucleic protein complex (RNP)–based genome editing approach for Schistosoma mansoni comparing Cas9 and Cas12a, the latter attained more efficient homology-directed insertion of a 5′-C6-PEG10–modified double-stranded donor template bearing 50-nucleotide microhomology arms into a genome safe-harbor site (GSH1). Electroporation of eggs recovered from host livers resulted in enhanced green fluorescent protein (EGFP) reporter activity, driven by an S. mansoni ubiquitin promoter and terminator. Hamster infection with transgenic cercariae, the infectious stage of this parasitic platyhelminth, recovered from miracidial infection of snails, or from sporocysts generated in vitro from transgenic miracidia and implantation in snails, produced EGFP-positive adult worms. Sequencing of the edited GSH1 and analyses of filial generations demonstrated chromosomal integration and the stable transformation of S. mansoni . Together, this approach advances schistosome transgenesis and may be pioneering for other platyhelminths, which lack functional genomics and transformation methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Parasitology, Biomedical Research Center Seltersberg (BFS), Justus Liebig University Giessen, Germany.
- Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, George Washington University, Washington, DC 20037, USA.
- Cellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
- IHPE Univ Perpignan Via Domitia, CNRS, IFREMER, Univ Montpellier, Perpignan, France.
ORCID-Profile: Max F Moescheid, Prapakorn Wisitpongpun, Vanessa Gross, Thomas Quack, Anne Rognon, Christoph Grunau, Wannaporn Ittiprasert, Paul J Brindley, Christoph G Grevelding
Förderung
- Wellcome Trust
- NIAID NIH HHS
- NCI NIH HHS
- NCRR NIH HHS
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Wellcome
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Moescheid, M. F., Wisitpongpun, P., Gross, V., Mann, V. H., Quack, T., Rognon, A., Grunau, C., Ittiprasert, W., Brindley, P. J., & Grevelding, C. G. (2026). Toward transgenic multicellular parasites: CRISPR-Cas12a germline editing of Schistosoma mansoni eggs as key to success. Science Advances. https://doi.org/10.1126/sciadv.aeh0455
Vancouver
Moescheid MF, Wisitpongpun P, Gross V, Mann VH, Quack T, Rognon A, et al. Toward transgenic multicellular parasites: CRISPR-Cas12a germline editing of Schistosoma mansoni eggs as key to success. Science Advances. 2026. doi:10.1126/sciadv.aeh0455
BibTeX
@article{Moescheid2026,
author = {Moescheid, Max F and Wisitpongpun, Prapakorn and Gross, Vanessa and Mann, Victoria H and Quack, Thomas and Rognon, Anne and Grunau, Christoph and Ittiprasert, Wannaporn and Brindley, Paul J and Grevelding, Christoph G},
title = {Toward transgenic multicellular parasites: CRISPR-Cas12a germline editing of Schistosoma mansoni eggs as key to success},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeh0455}
}
EUVIMED